Belite Bio, Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference Transcript

SA Transcripts159.5K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Belite Bio, Inc (BLTE) Deutsche Bank ADR Virtual Investor Conference April 28, 2026 9:00 AM EDT Company Participants Hendrik Scholl - Chief Medical Officer Conference Call Participants Zafar Aziz - Deutsche Bank Aktiengesellschaft Presentation Zafar AzizDeutsche Bank Aktiengesellschaft Hello, and welcome to the 30th Deutsche Bank Depository Receipts Virtual Investor Conference, dbVIC. My name is Zaf Aziz from the DR Investor Relations Advisory Team at Deutsche Bank. I'm pleased to announce that our next presentation will be from Belite Bio. Before handing over to our presenter, some points to note. Please submit your questions at any time throughout the presentation. Finally, all of our presentations will be recorded and can be access by the Deutsche Bank website, adr.db.com. At this point, I'm very pleased to welcome our speaker from Belite Bio. Hendrik SchollChief Medical Officer Thank you. Hello. I would like to welcome everybody to the presentation of Belite Bio. I just have to share my screen, here we are. All right. And I hope my screen can be seen. The title of my talk is early intervention with an oral treatment for macular degeneration. This is our forward-looking statement and legal disclaimer. My name is Hendrik Scholl. I'm the Chief Medical Officer of Belite Bio, and I must say that I can't see my slides here on the screen. I can't see -- are my slides being shown?

Unknown Attendee Yes, right now, I see the management team. Now the pipeline. Hendrik SchollChief Medical Officer Okay. So we see -- so what you see right now? You see the Belite Bio executive team?

Unknown Attendee Yes. And now disclaimer. Hendrik SchollChief Medical Officer Okay. So my name is Hendrik Scholl. I'm the Chief Medical Officer of Belite Bio. I'm a retinal specialist by training. Started my